Back to Top Skip to main content Skip to sub-navigation

MHS prepared to support interagency coronavirus response

Airmen assist one another in donning their personal protective equipment, while on-board an Air Force C-17 Globemaster III during transportation isolation system training at Joint Base Charleston, South Carolina. Engineered and implemented after the Ebola virus outbreak in 2014, the TIS is an enclosure the Department of Defense can use to safely transport patients with diseases like novel coronavirus. (U.S. Air Force photo by Senior Airman Cody R. Miller) Airmen assist one another in donning their personal protective equipment, while on-board an Air Force C-17 Globemaster III during transportation isolation system training at Joint Base Charleston, South Carolina. Engineered and implemented after the Ebola virus outbreak in 2014, the TIS is an enclosure the Department of Defense can use to safely transport patients with diseases like novel coronavirus. (U.S. Air Force photo by Senior Airman Cody R. Miller)

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus

The novel coronavirus (2019-nCoV) now affects more than 28 countries, with more than 28,000 cases worldwide. The Military Health System and Defense Health Agency remain prepared to support combatant commanders to protect our service members, other Department of Defense personnel, and their families in the United States and around the globe.

U.S. Army Col. (Dr.) Jennifer Kishimori, director, Chemical, Biological, Radiological, and Nuclear Medical Countermeasures Policy, Office of the Assistant Secretary of Defense for Health Affairs, recently briefed a U.S. Government interagency panel and health industry stakeholders on MHS actions and responsibilities. Foremost, Kishimori explained the DoD follows the guidance of the Centers for Disease Control and Prevention as the U.S. government medical lead.

“DoD is in support of the interagency for preparedness and response efforts against the novel coronavirus outbreak,” Kishimori said. “This is a new virus. Information is emerging and changing daily. Our Military Health System, which comprises the medical assets within the DoD, works to keep pace with CDC and interagency guidance in this fluid situation.”

Earlier, Acting Under Secretary of Defense for Personnel and Readiness Matthew P. Donovan released a guidance letter for force health protection specifically relating to the novel coronavirus. In it, Donovan stated that DoD will follow CDC guidance and provide specific instructions for DoD personnel and military health care professionals. While DoD personnel are not specifically at risk of exposure to the 2019-nCoV, the fact that DoD personnel and their families travel internationally and throughout the U.S. means they should take additional precautions to avoid risk.

Kishimori further explained DoD, through DHA, is distributing CDC-based guidance to health care providers and military families at all military treatment facilities. “Though our executing organizations such as the Defense Health Agency, we are working to communicate current CDC guidance for public health, hospital preparedness, patient evaluation, infection control, laboratory testing and health risk communication, in coordination with the Joint Staff.”

Specifically, DHA’s Medical Affairs directorate released information for health care providers to ensure any patient with a risk of infection receives the proper care and testing and that public health authorities are notified of all cases.

Kishimori outlined MHS’ unique capabilities to monitor and respond to 2019-nCoV for both surveillance and research and development.

  • The Center for Laboratory Medicine Services and the Executive Secretariat, DoD Laboratory Network synchronizes laboratory capability across the MHS and works with interagency partners to ensure supported network laboratories have the necessary detection and characterization capabilities in place to support 2019-nCoV-related activities across the globe.
  • DHA Armed Forces Health Surveillance Division and Global Emerging Infections Surveillance monitor daily the status of the outbreak.
  • Naval Medical Research Unit-2 in Phnom Penh, Cambodia, continues increased surveillance for the coronavirus at the China border.
  • The Armed Forces Research Institute of Medical Sciences in Thailand is also in a forward position to identify and characterize virus isolates.

The MHS also has a robust research capability with specific expertise in coronaviruses. Kishimori explained that the DoD has scientists and clinicians with experience in rapidly executing pre-clinical studies and virus vaccine clinical trials with infectious disease clinicians through DoD laboratories.

The CDC recommends simple measures to protect yourself from illness:

  • Avoid close contact with sick people.
  • While sick, limit contact with others as much as possible.
  • Stay home if you are sick.
  • Cover your nose and mouth when you cough or sneeze. Avoid touching your eyes, nose and mouth. Germs spread this way.
  • Clean and disinfect surfaces and objects that may be contaminated with germs.
  • Wash your hands often with soap and water for at least 20 seconds. If soap and water are not available, use an alcohol-based hand rub with at least 60 percent alcohol.

“Force Health Protection is our top priority in Health Affairs and the Department of Defense,” Kishimori explained. “The MHS continues to coordinate with DoD partners and the interagency to optimize preparedness and response efforts against the nCoV.”

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA-AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

DODI 6200.03: Public Health Emergency Management within the Department of Defense

Policy

In accordance with DoD Directive (DoDD) 5124.02, this issuance: • Establishes policy, assigns responsibilities, and provides direction to ensure mission assurance and readiness for public health emergencies caused by all-hazards incidents. • Defines a public health emergency within the DoD to include the occurrence or imminent threat of an illness or health condition that poses a high probability of a significant number of deaths, serious or long-term disabilities, widespread exposure to an infectious or toxic agent, overwhelmed health care resources, or severe degradation of mission capabilities. • Provides DoD policy for management of public health emergencies, in accordance with DoD Instruction (DoDI) 6055.17, through integration with the DoD Emergency Management (EM) Program. • Outlines the public health emergency health powers, roles, and responsibilities of the military installation commander, including the authority for restriction of movement. • Details procedures for internal and external notifications of DoD-declared public health emergencies. • Clarifies the PHEM roles and responsibilities of the medical treatment facility (MTF) commander or director, the public health emergency officer (PHEO), and the medical emergency manager (MEM).

  • Identification #: N/A
  • Date: 11/25/2019
  • Type: Instructions
  • Topics: Public Health

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.